Bagsværd, Denmark, 13 November 2024 - This company announcement discloses the data of the transaction(s) made in Novo Nordisk ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article ...

No adequate supply? Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk. (Photo: James ...

The Shelton Capital International Select Fund returned 7.91%, underperforming the MSCI AC World ex-US index by 0.15%, with ...

While it looks like Lilly may be entering yet a new growth period, there's a lingering competitive threat looming in the ...

Amgen is testing MariTide as a once-monthly shot, making it a promising potential rival to the weekly blockbuster weight-loss injections from Novo Nordisk and Eli Lilly. Tuesday's stock decline lopped ...

Fisher Asset Management's portfolio value increased to $244B, with top holdings in Apple, Microsoft, Nvidia, Amazon, and ...

The work provides novel genetic insights into dietary preferences and opens the possibility of targeting SI to selectively ...

Ginkgo Bioworks Holdings, Inc. , which is building the leading platform for cell programming and biosecurity, today announced its results for the third quarter ended September ...

However, there are currently no clinically approved ways to safely increase energy ... In 2023, Embark Biotech was acquired ...

However, there are currently no clinically approved ways to safely increase energy ... In 2023, Embark Biotech was acquired by Novo Nordisk to develop next generation therapeutics for cardiometabolic ...